Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-08-02
1996-10-15
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514119, 514407, 514471, 514542, 514551, 514563, 514565, 5483701, 549318, 560 37, 560169, 562442, 562561, A61K 31195, A61K 3805, C07C22902, C07K 5062
Patent
active
055654304
ABSTRACT:
Disclosed are compounds, compositions and methods for inhibiting interleukinprotease activity. The compounds, .alpha.-substituted acetamides a ##STR1## wherein: R.sub.2 =H or alkyl;
REFERENCES:
patent: 5430128 (1995-07-01), Chapman et al.
patent: 5434248 (1995-07-01), Chapman et al.
Bioorg. Med. Chem. Lett., vol. 2, No. 6, issued 1992, Chapman, "Synthesis of a Potent, Reversible Inhibitor . . . ", pp. 613-618.
Chem. Ber., vol. 102, issued 1969, Niedrich, "Synthese von substituierten 2.4-Bis . . . ", pp. 1557-1569.
Tet. Letters, vol. 26, No. 26, issued 1985, Moody et al, "Synthesis of Aza-.beta.-Lactams by Rhodium . . . ", pp. 3171-3172.
Chemical Abstracts 78: 72578c (1973).
Chemical Abstracts 88:38140a (1978).
Dolle Roland E.
Graybill Todd L.
Davis William J.
DuPont Paul E.
Russel Jeffrey E.
Sterling Winthrop Inc.
LandOfFree
Azaaspartic acid analogs as interleukin-1.beta. converting enzym does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaaspartic acid analogs as interleukin-1.beta. converting enzym, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaaspartic acid analogs as interleukin-1.beta. converting enzym will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246114